)
Visual
test
PW Medtech Group
PW Medtech Group (1358) investor relations material
PW Medtech Group H1 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2025 earnings summary29 Aug, 2025
Executive summary
Revenue rose 22.4% year-over-year to RMB414.4 million, driven by strong Blood Purification Business growth and the debut of Regenerative Medical Biomaterials revenue.
Gross profit increased 13.4% to RMB212.8 million, with gross margin at 51.3%, down from 55.4% due to pricing pressure and product mix.
Profit attributable to owners declined 6.0% to RMB66.0 million, mainly due to higher expenses and lower finance income.
Adjusted profit attributable to owners (non-HKFRS) rose 10.9% to RMB83.4 million, reflecting adjustments for share-based compensation, spin-off costs, and amortization.
Interim dividend of HK4.4 cents per share declared.
Financial highlights
Blood Purification Business revenue surged 44.5% year-over-year to RMB297.4 million, now 71.8% of total revenue.
Infusion Set Business revenue fell 14.5% to RMB113.4 million, impacted by volume-based procurement and soft demand.
Regenerative Medical Biomaterials Business recorded RMB3.5 million in its first revenue contribution.
Operating profit dropped 5.1% to RMB80.2 million; net finance income fell 17.5% to RMB22.9 million.
Cash and cash equivalents stood at RMB1,693.3 million as of June 30, 2025.
Outlook and guidance
Focus remains on expanding production, product portfolio, and international markets, especially for blood purification products.
Continued R&D investment and product registration efforts across all segments.
Management expects Regenerative Medical Biomaterials to become a new growth engine.
Ongoing response to centralized procurement and market reforms to maintain competitiveness.
Management sees opportunities in domestic substitution and international expansion despite procurement challenges.
VBP impact on Blood Purification margins?
Why Regenerative Medical G&A surge?
Sichuan Ruijian Medical spin-off update?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 6 FebHTOO
Resale registration for 71,429 shares via warrant, with proceeds only on exercise; financial risks persist. - 6 FebVSAT
Q3 revenue up 3% to $1.16B, net income $25M, strong cash flow, Ligado boost, satellite focus. - 6 FebWEC
Targets 7–8% EPS growth, $37.5B capex, and coal exit by 2032 amid surging data center demand. - 6 FebBR
Q2 FY26 recurring revenue grew 8% and adjusted EPS guidance was raised to 9-12%. - 6 FebFFWM
Merger vote includes new non-voting stock class with limited conversion and no voting rights. - 6 FebKKR
Charter amendments seek to modernize governance and establish one share, one vote by 2026. - 6 FebARI
Proposed $9B real estate loan portfolio acquisition highlights disciplined, long-term strategy. - 6 FebSMCI
Q2 revenue jumped 123% to $12.7B, with FY26 guidance raised to at least $40B. - 6 FebRJF
Record revenues and assets, higher dividend, and acquisitions despite lower net income. - 6 FebFFIE
Raising capital for global EV and AI expansion, with regulatory and dilution risks highlighted.
Next PW Medtech Group earnings date
H2 202527 Mar, 2026
PW Medtech Group
Next PW Medtech Group earnings date
H2 202527 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
PW Medtech Group Limited is a medical device company that specializes in the research, development, manufacture, and distribution of healthcare products primarily for use in China. The company’s product portfolio focuses on infusion sets, wound care, and regenerative biomaterial solutions, serving hospitals and healthcare providers in a range of therapeutic areas. The company is headquartered in Beijing, China, and its shares are listed on the HKEX.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage